EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Inflammation and Immune-Based Scores Predict Prognosis for Patients with Hepatocellular Carcinoma: A Pilot Single-Center Study

Merve Guzel Dirim, Asli Cifcibasi Ormeci, Bilger Cavus, Arzu Poyanli, Kursat Rahmi Serin, Filiz Akyuz, Kadir Demir, Selman Fatih Besisik, Sabahattin Kaymakoglu

Turkish Journal of Gastroenterology · 2025

DOI: 10.5152/tjg.2025.24407 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Turkish Journal of Gastroenterology, 2025. Verfasst von Merve Guzel Dirim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, İstanbul University İstanbul Faculty of Medicine, İstanbul, Türkiye. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Inflammation. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims: Hepatocellular carcinoma (HCC) ranks as a major contributor to cancer-related deaths. Systemic inflammation plays a pivotal role in HCC development and progression. Thus, we aimed to determine the impact of inflammation- and immune-based scores in predicting the prognosis of HCC. Materials and Methods: In this retrospective study, patients with HCC were enrolled between 2010 and 2020. The purpose of this ret rospective study was to evaluate the impact of various biomarkers, including baseline alpha fetoprotein (AFP) levels, C-reactive protein (CRP) –albu min–l ympho cyte (CALLY) index, neutrophil-to-CRP (N/CRP) ratio, systemic immune-inflammation index (SII), albumin–bili rubin (ALBI) score, neutr ophil -to-l ympho cyte ratio (NLR), and aspartate aminotransferase (AST)-to-alanine aminotransferase (ALT) (AST/ALT) ratio (AAR), on survival, invasion of vascular tracts, metastasis, and treatment responses.

Results

A total of 199 patients with complete (n = 44) and non-complete (n = 145) treatment response groups were enrolled in the study. All scores for the non-complete response group were statistically significant (P < .05). The areas under the curves for predicting a non-complete response group were 0.651, 0.649, 0.636, 0.625, 0.613, 0.609, and 0.600 for AFP, CALLY index, AAR, SII, N/CRP ratio, ALBI score, and NLR, respectively. These results are consistent with the assessment of mortality and HCC progression.

Conclusion

Our results indicate that these biomarkers could serve as powerful prognostic tools for HCC. Cite this article as: Guzel Dirim M, Cifcibasi Ormeci A, Cavus B, et al. Inflammation and immune-based scores predict prognosis for patients with hepatocellular carcinoma: A pilot single-center study. Turk J Gastroenterol. 2025;36(4):219-228.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsInflammationHumansMaleFemaleRetrospective StudiesMiddle AgedPrognosisPilot ProjectsC-Reactive Proteinalpha-FetoproteinsAgedAspartate AminotransferasesNeutrophilsBiomarkers, TumorAlanine TransaminaseBilirubinLymphocytesPredictive Value of TestsSerum AlbuminAdult

Stichwörter der Autor:innen

C-reactive protein–albumin–lymphocyte indexHepatocellular carcinomaalpha-fetoproteininflammation

Substanzen

C-Reactive Proteinalpha-FetoproteinsAspartate AminotransferasesBiomarkers, TumorAlanine TransaminaseBilirubinSerum Albumin

Autor:innen und Institutionen

  • Department of Internal Medicine, İstanbul University İstanbul Faculty of Medicine, İstanbul, Türkiye.
  • Division of Gastroenterohepatology, Department of Internal Medicine, İstanbul University İstanbul Faculty of Medicine, İstanbul, Türkiye.
  • Department of Radiology, İstanbul University İstanbul Faculty of Medicine, İstanbul, Türkiye.
  • Department of General Surgery, İstanbul University İstanbul Faculty of Medicine, İstanbul, Türkiye.

Zitieren

APA

Dirim, M. G., Cifcibasi Ormeci, A., Cavus, B., Poyanli, A., Serin, K. R., Akyuz, F., Demir, K., Besisik, S. F., & Kaymakoglu, S. (2025). Inflammation and Immune-Based Scores Predict Prognosis for Patients with Hepatocellular Carcinoma: A Pilot Single-Center Study. Turkish Journal of Gastroenterology. https://doi.org/10.5152/tjg.2025.24407

Vancouver

Dirim MG, Cifcibasi Ormeci A, Cavus B, Poyanli A, Serin KR, Akyuz F, et al. Inflammation and Immune-Based Scores Predict Prognosis for Patients with Hepatocellular Carcinoma: A Pilot Single-Center Study. Turkish Journal of Gastroenterology. 2025. doi:10.5152/tjg.2025.24407

BibTeX
@article{Dirim2025,
  author = {Dirim, Merve Guzel and Cifcibasi Ormeci, Asli and Cavus, Bilger and Poyanli, Arzu and Serin, Kursat Rahmi and Akyuz, Filiz and Demir, Kadir and Besisik, Selman Fatih and Kaymakoglu, Sabahattin},
  title = {Inflammation and Immune-Based Scores Predict Prognosis for Patients with Hepatocellular Carcinoma: A Pilot Single-Center Study},
  journal = {Turkish Journal of Gastroenterology},
  year = {2025},
  doi = {10.5152/tjg.2025.24407}
}
Kostenlos starten →